[1]李建民,王艳丽,王敏,等.中西医结合治疗高血压性脑出血微创术后患者临床疗效探讨[J].西部中医药,2020,33(S1):46.
 LI Jianmin,WANG Yanli,WANG Min,et al.Clinical Effects of Integrative Medicine in the Treatment for Hypertensive Intracerebral Hemorrhage after Minimally Invasive Surgery[J].Western Journal of Traditional Chinese Medicine,2020,33(S1):46.
点击复制

中西医结合治疗高血压性脑出血微创术后患者临床疗效探讨()
分享到:

《西部中医药》[ISSN:1006-6977/CN:61-1281/TN]

卷:
33
期数:
2020年S1
页码:
46
栏目:
出版日期:
2021-06-30

文章信息/Info

Title:
Clinical Effects of Integrative Medicine in the Treatment for Hypertensive Intracerebral Hemorrhage after Minimally Invasive Surgery
作者:
李建民王艳丽王敏尹云霞张世棋穆永茂张前进
迁安市人民医院,河北 迁安 064400 [
Author(s):
LI Jianmin WANG Yanli WANG Min YIN Yunxia ZHANG Shiqi MU Yongmao ZHANG Qianjin
Qianan City Peoples Hospital, Qianan 064400, China
关键词:
脑出血高血压性中西医结合通腑开窍涤痰手术作用机制 [
Keywords:
TCM hypertensive intracerebral hemorrhage surgery mechanism
分类号:
R [
文献标志码:
A
摘要:
目的:探讨通腑开窍涤痰中药辅助神经保护类西药治疗高血压性脑出血微创术后患者的临床疗效。方法:选取高血压脑出血微创术后患者共84例,以随机抽签法分为对照组和观察组,每组42例,对照组给予神经保护类西药,观察组在此基础上辅以通腑开窍涤痰中药治疗,比较2组患者临床疗效、治疗前后中医证候积分,美国国立卫生研究院卒中量表(NIHSS)评分,格拉斯哥昏迷指数(GCS)评分,日常生活能力评分(ADL)评分,炎症因子、氧化应激相关因子、巨噬细胞炎症蛋白-1α(MIP-1α)及胶质纤维酸性蛋白(GFAP)水平。结果:观察组临床疗效显著优于对照组(P<0.05);观察组治疗后中医证候积分、NIHSS评分、GCS评分及ADL评分均显著优于对照组、(P<0.05);观察组治疗后炎症因子和氧化应激相关因子水平均显著优于对照组(P<0.05);观察组治疗后MIP-1α和GFAP水平均显著低于对照组(P<0.05)。结论:通腑开窍涤痰中药辅助神经保护类西药用于高血压性脑出血微创术后患者治疗能够显著减轻其神经功能损伤,改善生存质量,并有助于抑制脑部炎症和异常氧化应激反应;而有效下调MIP-1α和GFAP水平可能是其疗效优势的重要作用机制。
Abstract:
Objective: To explore curative effects of the herbs of dredging-viscera, opening-orifice and removing-phlegm as adjunctive therapy combined with neuroprotective Western medicine in the treatment for hypertensive intracerebral hemorrhage (HIH) after minimally invasive medicine. Methods: All 84 patients were allocated to the control group and the observation group using random lotting method, 42 cases each group, the control group took neuroprotective Western medicine, and the observation group took the herbs of dredging-viscera, opening-orifice and removing-phlegm as adjunctive therapy based on Western medicine, to compare clinical effects, TCM syndrome scale before and after treating, NIHSS scores, GCS scores, ADL scores, the levels of inflammatory factors, oxidative stress related factors, MIP-1α and GFAP. Results: The observation group was superior to the control group in clinical effects notably (P<0.05); the observation group was better than the control group in TCM syndrome scores, NIHSS scores, GCS scores and ADL scores after treating notably (P<0.05); in the levels of inflammatory factors and oxidative stress related factors (P<0.05); the observation group was lower than the control group in the levels of MIP-1α and GFAP remarkably after treating (P<0.05). Conclusion: The herbs of dredging-viscera, opening-orifice and removing-phlegm as adjunctive therapy combined with neuroprotective Western medicine for HIH patients after minimally invasive medicine could notbaly relieve nerve function injury, improve survival quality and it is helpful to inhibit brain inflammation and abnormal oxidative stress reaction; whlle the regimen could effectively down regulate the levels of MIP-1α and GFAP, and it might be the significant mechanism of the advantages of clinical effects.

参考文献/References:

[1] 郭强,张爱莲,宋志斌,等.基底核区高血压脑出血术后患者生命质量及影响因素分析[J].中华物理医学与康复杂志,2016,38(7):514-523.

[2] 郑鲲,谭娟,冯辉斌,等.微创穿刺引流联合开颅血肿清除术对高血压脑出血合并脑疝患者预后的影响[J].山东医药,2015,55(30):74-75.

[3] 兰德彬,邹兴军,陈锐.高血压脑出血术后高压氧联合依达拉奉治疗对脑血管功能的影响[J].医学研究杂志,2016,45(1):166-169.

[4] 龙运军,吴兵兵,周德生,等.安脑平冲片对脑出血微创术后患者神经功能恢复及脑水肿和水通道蛋白的影响[J].中国中西医结合急救杂志,2016,23(4):356-359.

[5] 中华医学会神经病学分会.中国脑出血诊治指南(2014)[J].中华神经科杂志,2015,48(6):435-444.

[7] 孟靓靓,刘厚林.心脑血管疾病中西医治疗[M].北京:金盾出版社,2015:104-105.

[6] 于生元.脑血管病[M].北京:军事医学科学出版社,2014:204-205.

相似文献/References:

[1]李飞.针灸联合神经肌肉电刺激治疗脑出血伴吞咽障碍51例[J].西部中医药,2013,26(03):109.
 LI Fei.Acupuncture and Neuromuscular Electrical Stimulation in the Treatment for 51 Cases of Cerebral Hemorrhage Complicated with Dysphagia[J].Western Journal of Traditional Chinese Medicine,2013,26(S1):109.
[2]李西利.循证护理对脑出血患者生活质量的影响[J].西部中医药,2012,25(09):92.
 LI Xi-li.Effect of Evidence-Based Nursing on Life Quality of Patients with Cerebral Hemorrhage[J].Western Journal of Traditional Chinese Medicine,2012,25(S1):92.
[3]李兆蒲.早期适量放血疗法治疗高血压中小量脑出血38例[J].西部中医药,2012,25(08):92.
 LI Zhao-pu.Blood Letting Therapy in the Treatment for 38 Cases of Moderate or Small Amount of Hypertensive Intracerebral Hemorrhage at Early Stage[J].Western Journal of Traditional Chinese Medicine,2012,25(S1):92.
[4]袁魁珍,刘志娟,童守义,等.血栓通对超早期中小量脑出血患者血肿扩大的影响[J].西部中医药,2013,26(12):79.
 YUAN Kuizhen,LIU Zhijuan,TONG Shouyi,et al.Effects of XueShuanTong on Hematoma Enlargement of the Patients Suffering from Cerebral Hemorrhage with Moderate Amount of Bleeding at Super Early Stage[J].Western Journal of Traditional Chinese Medicine,2013,26(S1):79.
[5]李国达,贾平叶,史鹏程,等.水蛭粉合微创术治疗高血压性脑出血40例[J].西部中医药,2014,27(06):74.
 LI Guoda,JIA Pingye,SHI Pengcheng,et al.Leech and Minimally Invasive Surgery in Treating 40 Cases of Hypertensive cerebral Hemorrhage[J].Western Journal of Traditional Chinese Medicine,2014,27(S1):74.
[6]侯晓峰.醒脑静联合纳洛酮治疗急性脑出血40例[J].西部中医药,2015,28(08):99.
[7]李学文.中西医结合治疗高血压脑出血术后患者35例[J].西部中医药,2015,28(08):101.
[8]孙博,周其辉.七叶皂苷钠联合甘露醇治疗脑出血53例[J].西部中医药,2017,30(04):97.
 SUN Bo,ZHOU Qihui.Combination of Sodium Aeseinate and Mannitol in the Treatment of 53 Patients with Intracerebral Hemorrhage[J].Western Journal of Traditional Chinese Medicine,2017,30(S1):97.
[9]金亚娟,曹旸,李世敬.依达拉奉联合醒脑静治疗脑出血49例[J].西部中医药,2019,32(08):89.
 JIN Yajuan,CAO Yang,LI Shijing.Edaravone Combined with Xingnaojing in the Treatment for 49 Cases of Encephalorrhagia[J].Western Journal of Traditional Chinese Medicine,2019,32(S1):89.
[10]王威,赵海滨,马迪.涤痰通瘀方对急性脑出血大鼠肝组织核因子-κB活性与TNF-α表达的干预作用[J].西部中医药,2020,33(06):24.[doi:10.12174/j.issn.1004-6852.2020.06.06]
 WANG Wei,ZHAO Haibin,MA Di.Intervention Effects of Ditan Tongyu Prescription on the Activity of NF - κB and the Expressions of TNF-α in Liver Tissue of the Rats Suffering Acute Cerebral Hemorrhage[J].Western Journal of Traditional Chinese Medicine,2020,33(S1):24.[doi:10.12174/j.issn.1004-6852.2020.06.06]

备注/Memo

备注/Memo:
收稿日期:2019-06-25 作者简介:李建民(1977—),男,副主任医师。
更新日期/Last Update: 2020-04-01